The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.
Tagraxofusp, azacitidine, and venetoclax (TAG-AZA-VEN) triplet therapy shows efficacy, tolerability, and transplant potential in patients with blastic plasmacytoid dendritic cell neoplasm, according to
The first session of the Community Oncology Brown Bag Series hosted by SOHO Insider was held on January 20, 2026, and featured guest
“I’m quite emotional about this presidency,” Dr. Santini said in a Pathways & Perspectives interview with SOHO Insider. “I’m incredibly honored to become
In this podcast episode recorded at the Thirteenth Annual Meeting of the Society of Hematologic Oncology (SOHO 2025), Megan Melody, MD, from Tampa
The inaugural SOHO Asia meeting marked an important step toward strengthening hematology education and collaboration across the Asia-Pacific region, according to meeting leaders.
Recorded at the 67th American Society of Hematology Annual Meeting and Exposition in Orlando, Florida, Kelly Bolton, MD, PhD, assistant professor of medicine
Dr. Kamdar gives a sneak peek to her FREE virtual talk on “Expanding access to CAR T-cell therapy outside academic centers.” Go to
In this episode of the SOHO Insider podcast, Douglas Tremblay discusses how to approach the treatment of essential thrombocythemia.
How one patient traveled to China to pursue an experimental therapy that changed what was possible in multiple myeloma.
In this episode of the SOHO Insider podcast, Thomas Martin, MD, professor of medicine at University of California, San Francisco, talks with patient
